Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion SR and Nicotine Patch for Smoking Cessation in Schizophrenia
NCT00124683Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Sep 2001
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in Tobacco Use Disorder (TUD) comparing Nicotine Patch + Bupropion with Nicotine patch + placebo (2 arms). Primary endpoint: 7 day point prevalence of cigarette abstinence at 10 weeks. Started Sep 2001; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00124683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00124683.